GR3004983T3 - - Google Patents

Info

Publication number
GR3004983T3
GR3004983T3 GR920401318T GR920401318T GR3004983T3 GR 3004983 T3 GR3004983 T3 GR 3004983T3 GR 920401318 T GR920401318 T GR 920401318T GR 920401318 T GR920401318 T GR 920401318T GR 3004983 T3 GR3004983 T3 GR 3004983T3
Authority
GR
Greece
Application number
GR920401318T
Other languages
Greek (el)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888823488A external-priority patent/GB8823488D0/en
Priority claimed from GB898901095A external-priority patent/GB8901095D0/en
Priority claimed from GB898917201A external-priority patent/GB8917201D0/en
Application filed filed Critical
Publication of GR3004983T3 publication Critical patent/GR3004983T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GR920401318T 1988-10-06 1992-06-18 GR3004983T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB888823488A GB8823488D0 (en) 1988-10-06 1988-10-06 N-imidazolyl-& n-imidazolylmethyl-derivatives of substituted bicyclic compounds
GB898901095A GB8901095D0 (en) 1989-01-18 1989-01-18 N imidazolymethyl derivatives of bicyclic compounds and process for their preparation
GB898917201A GB8917201D0 (en) 1989-07-27 1989-07-27 N-imidazolyl-and n-imidazolylmethyl-derivatives of exo-alkylidene substituted bicyclic compounds

Publications (1)

Publication Number Publication Date
GR3004983T3 true GR3004983T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-04-28

Family

ID=27264115

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920401318T GR3004983T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1988-10-06 1992-06-18

Country Status (18)

Country Link
US (1) US5204364A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (2) EP0389613A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPH03501859A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR900701760A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU620647B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE68901441D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK137590A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2033062T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI902774A7 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR3004983T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU208123B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE893204L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL91542A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MY (1) MY106401A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ230629A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT91913B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO1990003970A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
YU (1) YU47002B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8705174D0 (en) * 1987-03-05 1987-04-08 Ici Plc Heterocyclic compounds
EP0457716A1 (de) * 1990-04-20 1991-11-21 Ciba-Geigy Ag Naphthalinderivate
GB2244431A (en) * 1990-05-31 1991-12-04 Farmos Oy Treatment of age related memory impairment and other cognitive disorders
EP0535232A4 (en) * 1990-06-22 1993-05-05 Taisho Pharmaceutical Co. Ltd Naphthothiopyranone derivative
GB9025848D0 (en) * 1990-11-28 1991-01-09 Erba Carlo Spa Imidazol-2-yl derivatives of substituted bicyclic compounds and process for their preparation
GB9101375D0 (en) * 1991-01-22 1991-03-06 Erba Carlo Spa N-imidazolyl derivatives of substituted tetrahydrocarbazole and cyclohepht(b)indole
GB9102862D0 (en) * 1991-02-11 1991-03-27 Erba Carlo Spa N-imidazolyl derivatives of substituted or alkoxymino tetrahydronaphthalenes and chromans
GB9108811D0 (en) * 1991-04-24 1991-06-12 Erba Carlo Spa N-imidazolyl derivatives of substituted indole
GB9127050D0 (en) * 1991-12-20 1992-02-19 Orion Yhtymae Oy Substituted imidazole derivatives and their preparation and use
GB9200689D0 (en) * 1992-01-14 1992-03-11 Rhone Poulenc Agriculture New compositions of matter
GB9509888D0 (en) * 1995-05-16 1995-07-12 Pharmacia Spa Terpenoidic derivatives useful as antitumour agents
GB9520150D0 (en) 1995-10-03 1995-12-06 Orion Yhtymae Oy New imidazole derivatives
JPH11106381A (ja) * 1997-09-30 1999-04-20 Ss Pharmaceut Co Ltd クロメン誘導体及びその塩並びにこれを含有する医薬
US6503935B1 (en) 1998-08-07 2003-01-07 Abbott Laboratories Imidazoles and related compounds as α1A agonists
EP2094669A2 (en) * 2006-12-18 2009-09-02 Novartis AG 1-substituted imidazole derivatives and their use as aldosterone synthase inhibitors

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3485917A (en) * 1966-04-14 1969-12-23 Janssen Pharmaceutica Nv Composition and method for combating fungus with imidazole carboxylates
US3541109A (en) * 1968-06-25 1970-11-17 Du Pont 1-substituted imidazoles useful in acth reserve assay
US3637731A (en) * 1968-07-18 1972-01-25 Du Pont 1-(alkylsubstituted phenyl)imidazoles useful in acth reserve assay
US3636002A (en) * 1969-12-15 1972-01-18 Janssen Pharmaceutica Nv 1-(2-halobenzyloxy-1-indanyl)-imidazoles
DE2244761A1 (de) * 1972-09-09 1974-03-14 Schering Ag Indan- und tetralinderivate
IE40911B1 (en) * 1974-04-11 1979-09-12 Schering Ag Imidazole derivatives and process for their manufacture
US3992403A (en) * 1975-05-30 1976-11-16 Schering Corporation 2-Imidazolines and their use as hypoglycemic agents
US4115578A (en) * 1975-12-18 1978-09-19 Rohm And Haas Company 1-Substituted aralkyl imidazoles
US4118461A (en) * 1975-12-18 1978-10-03 Rohm And Haas Company 1-Substituted aralkyl imidazoles
US4172141A (en) * 1976-03-17 1979-10-23 Syntex (U.S.A.) Inc. N-(naphthylethyl)imidazole derivatives
US4150153A (en) * 1977-05-13 1979-04-17 Syntex (U.S.A.) Inc. 1-(Naphthylethyl)imidazole derivatives
US4284641A (en) * 1977-08-26 1981-08-18 Burroughs Wellcome Co. Pharmaceutically active imidazole derivatives
JPS5452078A (en) * 1977-08-26 1979-04-24 Wellcome Found 11alkylimidazole and its manufacture
EP0003732B1 (en) * 1978-02-01 1983-10-19 The Wellcome Foundation Limited Imidazole derivatives and salts thereof, their synthesis, and pharmaceutical formulations thereof
US4218461A (en) * 1979-08-15 1980-08-19 E. R. Squibb & Sons, Inc. 2,3-Dihydro-2-[(1H-imidazol-1-yl)-methylene]-1H-inden-1-ones
US4500540A (en) * 1979-12-26 1985-02-19 Hoffmann-La Roche Inc. Thromboxane synthase inhibitors as insulin lowering agents and antionbesity agents
GB2071655B (en) * 1980-03-04 1983-06-22 Erba Farmitalia N-amidazolyl derivatives of1-chroman and process for their preparation
IL62122A0 (en) * 1980-03-04 1981-03-31 Erba Farmitalia N-imidazolyl derivatives of 1-chroman,their preparation and pharmaceutical compositions containing them
GR75101B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1980-10-23 1984-07-13 Pfizer
IL66242A0 (en) * 1981-07-23 1982-11-30 Erba Farmitalia N-imidazolyl derivatives of 1,2,3,4-tetrahydro-naphthalene,indan and 2-substituted-1-chroman,their preparation and pharmaceutical compositions containing them
GB2122997B (en) * 1982-07-05 1985-08-14 Erba Farmitalia Imidazoles
ES523609A0 (es) * 1982-07-05 1985-03-01 Erba Farmitalia Procedimiento para preparar derivados n-imidazolilicos de compuestos biciclicos.
PH22076A (en) * 1983-08-25 1988-05-20 Daiichi Seiyaku Co Benzocycloalkane derivative
US4634705A (en) * 1984-06-06 1987-01-06 Abbott Laboratories Adrenergic amidines
NZ219311A (en) * 1986-02-27 1989-04-26 Janssen Pharmaceutica Nv Imidazoles and herbicidal compositions
PH24144A (en) * 1987-06-03 1990-03-22 Erba Carlo Spa A method of treating nephropathies using n-imidazolyl derivatives of bicyclic compounds
IL86846A (en) * 1987-07-01 1992-03-29 Daiichi Seiyaku Co Pharmaceutical compositions for preventing and treating heart failure containing indane or naphthalene carboxylic acids
CA1314224C (en) * 1987-07-07 1993-03-09 Shinichiro Ashida Antidiabetic agent
US4808627A (en) * 1987-12-16 1989-02-28 E. R. Squibb & Sons, Inc. Method of preventing or treating toxemia in pregnancy using a thromboxane A2 receptor antagonist
GB8914525D0 (en) * 1989-06-23 1989-08-09 Erba Carlo Spa Combined use of n-imidazolyl derivatives of bicyclic compounds and cyclosporine in therapy

Also Published As

Publication number Publication date
ES2033062T3 (es) 1993-03-01
HU208123B (en) 1993-08-30
HUT58705A (en) 1992-03-30
EP0363789A1 (en) 1990-04-18
FI902774A0 (fi) 1990-06-04
KR900701760A (ko) 1990-12-04
FI902774A7 (fi) 1990-06-04
WO1990003970A1 (en) 1990-04-19
US5204364A (en) 1993-04-20
PT91913A (pt) 1990-04-30
PT91913B (pt) 1995-05-31
NZ230629A (en) 1990-12-21
DK137590A (da) 1990-08-06
MY106401A (en) 1995-05-30
JPH03501859A (ja) 1991-04-25
YU192989A (en) 1991-02-28
DE68901441D1 (de) 1992-06-11
IE893204L (en) 1990-04-06
YU47002B (sh) 1994-11-15
AU620647B2 (en) 1992-02-20
AU4344689A (en) 1990-05-01
DK137590D0 (da) 1990-06-01
IL91542A0 (en) 1990-04-29
EP0389613A1 (en) 1990-10-03
EP0363789B1 (en) 1992-05-06

Similar Documents

Publication Publication Date Title
EP0683530A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP0709716A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR3004983T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE3991756T (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE3872518D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP0764674A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR2626243B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU8268587A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU7157587A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU7574987A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU7813187A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU7900787A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU1329088A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU1439288A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK69788D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK578488D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK491288D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK404388D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU1456688A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU6860287A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU1324188A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BG45322A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU6002390A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BG45232A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BG45239A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)